Swedish Orphan Biovitrum
Anis Ben Kheder currently serves as Senior Director and Head of Patient Access for Region Europe at Sobi - Swedish Orphan Biovitrum AB, with responsibilities that include leading global patient access and pricing strategies for rare diseases in multiple therapy areas. Prior experience includes roles as Global Market Access & Pricing Manager at Servier, focusing on neuropsychiatry products, and Market Access Project Manager at Boehringer Ingelheim, where a loss of exclusivity strategy for respiratory drugs was developed. Earlier roles involved market access and pricing analysis at AbbVie and marketing project management at GMG santé. Anis obtained a Master’s degree in Pharmacoeconomics from Université Paris Dauphine and a Doctor of Pharmacy from the University of Montpellier.
This person is not in any teams
This person is not in any offices
Swedish Orphan Biovitrum
9 followers
Sobi is a specialised international biopharmaceutical company transforming the lives of people with rare diseases.